When patients with acute renal failure or vancomycin exposure within @days prior to study medication were excluded , clinical cure rates in the < @g/mL , @g/mL to < @g/mL , and@g/mL vancomycin trough level groups ( @ % -LSB- @/@ -RSB- , @ % -LSB- @/@ -RSB- , and @ % -LSB- @/@ -RSB- , respectively ; p = @ ) and the number of deaths ( @ % -LSB- @/@ -RSB- , @ % -LSB- @/@ -RSB- , and @ % -LSB- @/@ -RSB- , respectively ; p = @ ) demonstrated a trend towards worse outcomes in the higher vancomycin trough level groups .